✦ LIBER ✦

863 LONG-TERM SURVIVAL WITH INHALATIONAL IL-2 THERAPY IN CARDIAC HIGH RISK PATIENTS WITH METASTATIC RENAL CARCINOMA

✍ Scribed by C. Eichelberg; A. Andreas; H. Heinzer; E. Huland; H. Huland

Book ID: 119618180
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 330 KB
Volume: 6
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(07)60858-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

LONG-TERM TUMOR CONTROL WITH INHALATIONA

LONG-TERM TUMOR CONTROL WITH INHALATIONAL INTERLEUKIN 2 THERAPY IN CARDIAC HIGH RISK PATIENTS WITH METASTATIC RENAL CARCINOMA

✍ Eichelberg, Christian; Andreas, Anja; Heuer, Roman; Huland, Hartwig; Heinzer, Ha 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 139 KB

Survival analysis in patients with pulmo

Survival analysis in patients with pulmonary metastatic renal cell carcinoma (MRCC) treated by inhaled interleukin-2 (IL-2) compared to prognostic stratification models

✍ H. Heinzer; M. Toma; E. Huland; H. Huland 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Long term follow up of 50 patients with

Long term follow up of 50 patients with metastatic renal cell carcinoma treated with high dose i.v. interleukin. 2

✍ Libra, M.; Buonadonna, A.; Freschi, A.; Bearz, A.; Berretta, M.; Balestreri, L.; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 164 KB

163 - Autoimmunity induced by interleuki

163 - Autoimmunity induced by interleukin-2 and interferon-α is associated with long-term survival in patients with metastatic renal cell carcinoma

✍ A. Franzke; M. Probst; J. Buer; F. Wittke; R. Hoffmann; H. Kirchner; A. Ganser; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 226 KB

CYTOREDUCTIVE SURGERY BEFORE HIGH DOSE I

CYTOREDUCTIVE SURGERY BEFORE HIGH DOSE INTERLEUKIN-2 BASED THERAPY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

✍ Walther, McClellan M.; Yang, James C.; Pass, Harvey I.; Linehan, W. Marston; Ros 📂 Article 📅 1997 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 499 KB

High risk patients with pulmonary metast

High risk patients with pulmonary metastases of renal cell carcinoma: Safety and efficacy of inhaled interleukin-2 (IL-2) compared to systemic IL-2

✍ E. Huland; H. Heinzer; H. Huland 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 199 KB